Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Relief for Cancer Patients: OSU's Dr. Benjamin Kaffenberger on an Ongoing Dermatologic Study

On the new Prognosis Ohio, part of the WCBE Podcast Experience, Dan Skinner talks with OSU dermatologist and researcher, Benjamin Kaffenberger, MD, about a study he is leading to develop new drugs that aim to relieve cancer patients of pain caused by cancer treatments, known as 'Hand-Foot Skin Reaction'. Topics include cancer care, dermatology and its relationship with oncology, the cost of pharmaceuticals, and more.

On the show, Skinner and Kaffenberger address the clinical trial Kaffenberger is leading. You can read up on Hand-Foot Skin Reaction here and Vascular Endothelial Growth Receptor Inhibitor (VEGFRi) here. For information on the Pharma startup that is leading these efforts, you can check the OnQuality website, especially their pipeline. For information on the NIH funding, go here.

In the episode, Dan mentioned a book that he highly recommends (and which won a Pulitzer) by Siddhartha Mukherjee. Read about the book here, on Mukherjee's website.

For recent episodes of Prognosis Ohio addressing issues relevant to this episode, you can see the tags for cancer and pharmaceuticals on the Prognosis Ohio website.

Hosted and Produced by Dan Skinner (Twitter). 

Prognosis Ohio is part of the Health Podcast Network.

Dr. Dan Skinner is Associate Professor of Health Policy in the Department of Social Medicine at Ohio University, Heritage College of Osteopathic Medicine, on the Dublin, Ohio campus. He earned his Ph.D. in political science from the City University of New York. Skinner teaches and researches about, as well as advocates for increased access to health care, especially for underserved populations, as well as various aspects of social determinants that affect the health of communities, in Ohio and beyond.
Related Content